Alzheimer’s Disease and Its Potential Alternative Therapeutics

Alzheimer’s Disease (AD) is a chronic neurodegenerative disease that affects over 5 million individuals in the United States alone. Currently, there are only two kinds of pharmacological interventions available for symptomatic relief of AD; Acetyl Cholinesterase Inhibitors (AChEI) and N-methyl-D-asp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kisby, Brent, Jarrell, Juliet T, Agar, M Enes, Cohen, David S, Rosin, Eric R, Cahill, Catherine M, Rogers, Jack T, Huang, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777730/
https://www.ncbi.nlm.nih.gov/pubmed/31588368
http://dx.doi.org/10.4172/2161-0460.1000477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777730/
https://www.ncbi.nlm.nih.gov/pubmed/31588368
http://dx.doi.org/10.4172/2161-0460.1000477

Ejemplares similares